[1] Braamskamp MJAM,Wijburg FA,Wiegman A.Drug therapy of hypercholesterolaemia in children and adolescents[J].Drugs,2012,72 (6):759-772. [2] Descamps OS,Tenoutasse S,Stepbenne X,et al.Management of familial hypercholesterolemia in children and young adults:consensus paper developed by a panel of lipidologists,cardiologists,paediatricians,nutritionists,gastroenterologists,general practitioners and a patient organization[J].Atherosclerosis,2011,218(2):272-280. [3] Friend A,Craig L,Turner S.The prevalence of metabolic syndrome in children:a systematic review of the literature[J].Metab Syndr Relat Disord,2013,11(2):71-80. [4] Zhang Y,Zhou JY,Zhao JS,et al.Urban-rural and regional disparities in the prevalence of elevated blood pressure among children and adolescents in Shandong,China[J].Int J Cardiol,2014,3(176):1053-1055. [5] 吴剑云,杨东,孙玉贞,等.东莞市横沥镇3-17岁儿童少年肥胖与高血压流行情况及危险因素分析[J].中国儿童保健杂志,2014,22(11):1191-1195. [6] Redwine KM,Acosta AA,Poffenbarger T,et al.Development of hypertension in adolescents with pre-hypertension[J].J Pediatr,2012,160(1):98-103. [7] 刘小晖,魏晶,李泽民,等.青岛市中小学生肥胖与血压关系分析[J].中国儿童保健杂志,2013,21(11):1209-1211. [8] Bonita F.Hypertension in children and adolescents:epidemiology and natural history[J].Pediatr Nephrol,2010,25(7):1219-1224. [9] Alsifri SN,Almahmeed W,Azar S,et al.Results of the dyslipidemia international study (DYSIS)-Middle East:clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment[J].PLoS One,2014,9:e84350. [10] Prasanta KB,Utpala D,Dipankar B,et al.Distribution of blood pressure & correlates of hypertension in school children aged 5-14 years from Northeast India[J].Indian J Med Res,2015,142(3):293-300. [11] 齐可民.儿童青少年血脂异常的特点与治疗[J].中华实用儿科临床杂志,2013,28(19):1510-1513. [12] 刘益民,胡虞志,周德.儿童血压水平与血脂关系的研讨[J].中国学校卫生,1990,11(5):29-31. [13] 董彬,马军,黄志达,等.青春期学生血压变化规律分析[J].中国学校卫生,2012,33(2):137-139. [14] Borghi C,Cicero AFG,Saragoni S,et al.Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice[J].Ann Med,2014,46:97-102. [15] Deventer HE,Miller WG,Myers GL.Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population[J].Clin Chem,2011,57(3):490-501. [16] van Deventer HE,Miller WG,Myers GL,et al.Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population[J].Clin Chem,2011,57:490-501. [17] Srinivasan SR,Frontini MG,Xu J,et al.Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemic and other cardiovascular risks:the Bogalusa Heart Study[J].Pediatrics,2006,118:201-206. [18] 陈联辉,施锡锋,梁黎.非高密度脂蛋白胆固醇的临床意义及其在儿科中的应用[J].中华儿科杂志,2013,51(6):436-438. [19] Ruben OH,Howard DS,Jing M.Dyslipidemia and the Risk of Incident Hypertension in Men[J].Hypertension,2006,47:45-50. [20] McGill HC,McMahan CA,Gidding SS.Preventing heart disease in the 21st century implications of the pathobiological determinants of atherosclerosis in youth (PDAY) study[J].Circulation,2008,117:1216-1227. |